Enanta Pharmaceuticals
ENTA
#7512
Rank
ยฃ0.30 B
Marketcap
ยฃ10.56
Share price
-1.60%
Change (1 day)
92.56%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of June 2025 : ยฃ59.19 Million

According to Enanta Pharmaceuticals 's latest financial reports the company has ยฃ59.19 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2024-09-30$ยฃ96.3 M-45.81%
2023-09-30$ยฃ0.17 B-38.47%
2022-09-30$ยฃ0.28 B-2.61%
2021-09-30$ยฃ0.29 B-15.92%
2020-09-30$ยฃ0.35 B-6.28%
2019-09-30$ยฃ0.37 B24.64%
2018-09-30$ยฃ0.30 B34.07%
2017-09-30$ยฃ0.22 B8.13%
2016-09-30$ยฃ0.20 B33.37%
2015-09-30$ยฃ0.15 B70.31%
2014-09-30$ยฃ91.68 M34.35%
2013-09-30$ยฃ68.24 M150.5%
2012-09-30$ยฃ27.24 M93.8%
2011-09-30$ยฃ14.05 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AbbVie
ABBV
-ยฃ1.95 Billion-3,378.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ59.19 B 99,897.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ12.93 B 21,745.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ38.75 B 65,373.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ13.88 B 23,361.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ33.41 B 56,348.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland